TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 18465719

Group type: EXPERIMENTAL
Intervention: Silicone IOL (AQ110NV)
Number of subjects: 339

Group type: COMPARATOR
Intervention: Rigid PMMA IOL (811C or 824C)
Number of subjects: 339

Group type: COMPARATOR
Intervention: Acrylic IOL (MA60BM)
Number of subjects: 339
Study: 15223898

Group type: EXPERIMENTAL
Intervention: Two-dose basiliximab with low initial CsA triple therapy (group B)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Conventional triple therapy (group C)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Combined analysis of groups B and C
Number of subjects: 45
Study: 11725330

Group type: EXPERIMENTAL
Intervention: Creatine supplementation (20 g/d for 6 days, then 6 g/d for 4 weeks)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 9394363

Group type: EXPERIMENTAL
Intervention: Gemcitabine (Gemzar)
Number of subjects: 0
Study: 8215564

Group type: EXPERIMENTAL
Intervention: Low dosage surfactant regimen (100 mg/kg initially, with two further doses at 12 and 24 hours to a maximum cumulative total of 300 mg/kg; n = 1069)
Number of subjects: 2178

Group type: COMPARATOR
Intervention: High dosage surfactant regimen (200 mg/kg initially with up to four further doses of 100 mg/kg to a maximum cumulative total of 600 mg/kg; n = 1099)
Number of subjects: 2178

Group type: EXPERIMENTAL
Intervention: Low dosage surfactant regimen
Number of subjects: 2178

Group type: COMPARATOR
Intervention: High dosage surfactant regimen
Number of subjects: 2178
Study: 3828659

Group type: EXPERIMENTAL
Intervention: Bilateral electroconvulsive therapy (ECT)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Simulated ECT (muscle relaxant and anaesthesia)
Number of subjects: 70
Study: 31515428

Group type: EXPERIMENTAL
Intervention: Methotrimeprazine 6.25 mg
Number of subjects: 116

Group type: COMPARATOR
Intervention: Haloperidol 1.5 mg
Number of subjects: 116
Study: 26975312

Group type: EXPERIMENTAL
Intervention: Transregional interferential current therapy (10 sessions of 25 minutes over two weeks)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Usual care (massage, mobilization, and soft-tissue techniques)
Number of subjects: 64
Study: 26033051

Group type: EXPERIMENTAL
Intervention: Standard infiltration of local anaesthetic
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Reversed infiltration of local anaesthetic
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study: 24273182

Group type: EXPERIMENTAL
Intervention: CVD 908-htrA vaccine in H. pylori infected subjects
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: CVD 908-htrA vaccine in subjects with low PG I:PG II ratio (<5)
Number of subjects: 74

Group type: COMPARATOR
Intervention: CVD 908-htrA vaccine in H. pylori uninfected subjects
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: CVD 908-htrA vaccine with Hepatitis A infection
Number of subjects: 74
Study: 22938439

Group type: EXPERIMENTAL
Intervention: Continuous transarterial infusion chemotherapy with gemcitabine (1000 mg/m2) and 5-Fluorouracil (600 mg/m2)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Systemic venous chemotherapy with gemcitabine (1000 mg/m2) and 5-Fluorouracil (600 mg/m2)
Number of subjects: 48
Study: 19692345

Group type: EXPERIMENTAL
Intervention: Brief Intervention (BI)
Number of subjects: 494

Group type: COMPARATOR
Intervention: Control (no brief intervention)
Number of subjects: 494
Study: 17567623

Group type: EXPERIMENTAL
Intervention: Pravastatin
Number of subjects: 3304

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 3304
Study: 15205720

Group type: EXPERIMENTAL
Intervention: 5 mg ALN
Number of subjects: 445

Group type: EXPERIMENTAL
Intervention: 10 mg ALN
Number of subjects: 445

Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 445

Group type: EXPERIMENTAL
Intervention: 20 mg ALN
Number of subjects: 445
Study: 11686821

Group type: EXPERIMENTAL
Intervention: Chlorhexidine acetate/xylitol gum (ACHX)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Xylitol gum (X)
Number of subjects: 111

Group type: COMPARATOR
Intervention: No gum (N)
Number of subjects: 111
Study: 9142362

Group type: EXPERIMENTAL
Intervention: special program
Number of subjects: 125
Study: 7962393

Group type: EXPERIMENTAL
Intervention: Endometriosis in women with sterility (660 subjects)
Number of subjects: 3684

Group type: EXPERIMENTAL
Intervention: Endometriosis in women with chronic pelvic pain (409 subjects)
Number of subjects: 3684

Group type: EXPERIMENTAL
Intervention: Endometriosis in women with fibroids (1880 subjects)
Number of subjects: 3684

Group type: EXPERIMENTAL
Intervention: Endometriosis in women with benign ovarian cysts (735 subjects)
Number of subjects: 3684

Group type: EXPERIMENTAL
Intervention: Stage distribution of endometriosis in women with sterility
Number of subjects: 3684

Group type: EXPERIMENTAL
Intervention: Stage distribution of endometriosis in women with pelvic pain
Number of subjects: 3684

Group type: EXPERIMENTAL
Intervention: Stage distribution of endometriosis in women with fibroids
Number of subjects: 3684

Group type: EXPERIMENTAL
Intervention: Stage distribution of endometriosis in women with ovarian cysts
Number of subjects: 3684
Study: 3305850

Group type: EXPERIMENTAL
Intervention: Theophylline
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo and diuretics
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Theophylline and diuretics
Number of subjects: 16
Study: 30259166

Group type: EXPERIMENTAL
Intervention: 11 PTS and drains
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: 22 PTS and drains
Number of subjects: 63

Group type: COMPARATOR
Intervention: Classic abdominoplasty without PTS and drains
Number of subjects: 63
Study: 26944407

Group type: EXPERIMENTAL
Intervention: SRP + probiotic (Lactobacillus rhamnosus SP1), n = 14
Number of subjects: 28

Group type: COMPARATOR
Intervention: SRP + placebo (control), n = 14
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: SRP + probiotic (Lactobacillus rhamnosus SP1)
Number of subjects: 28

Group type: COMPARATOR
Intervention: SRP + placebo (control)
Number of subjects: 28
Study: 24787494

Group type: EXPERIMENTAL
Intervention: Moderate-carbohydrate and low-GI diet (LGI)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Low-fat and high-GI diet (LF)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Moderate-carbohydrate and high-GI diet (HGI)
Number of subjects: 122
Study: 22673263

Group type: EXPERIMENTAL
Intervention: Serum levels of ubiquitin C-terminal hydrolase (UCH-L1) in TBI patients
Number of subjects: 295

Group type: EXPERIMENTAL
Intervention: Serum levels of ubiquitin C-terminal hydrolase (UCH-L1) in TBI patients with neurosurgical intervention (NSI)
Number of subjects: 295

Group type: EXPERIMENTAL
Intervention: Serum levels of ubiquitin C-terminal hydrolase (UCH-L1) in TBI patients with GCS score 15
Number of subjects: 295
Study: 20362712

Group type: EXPERIMENTAL
Intervention: Cryoballoon catheter
Number of subjects: 244

Group type: COMPARATOR
Intervention: Open irrigated radiofrequency ablation
Number of subjects: 244
Study: 18270772

Group type: EXPERIMENTAL
Intervention: Robotic tumor-specific mesorectal excision (R-TSME)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Conventional laparoscopic tumor-specific mesorectal excision (L-TSME)
Number of subjects: 36
Study: 15745109

Group type: EXPERIMENTAL
Intervention: Band ligation (group A; n = 16)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Beta-blockers (group B; n = 15)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 31
Study: 11785558

Group type: EXPERIMENTAL
Intervention: Supine position
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Lateral with allograft lung down
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Lateral with native lung down
Number of subjects: 15
Study: 10598223

Group type: EXPERIMENTAL
Intervention: Percutaneous suture (group T)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Manual compression (group C)
Number of subjects: 100
Study: 7750282

Group type: EXPERIMENTAL
Intervention: Nestorone subdermal implant (Implant A)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Nestorone subdermal implant (Implant B)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Nestorone subdermal implant
Number of subjects: 70

Group type: COMPARATOR
Intervention: Copper T users (Control)
Number of subjects: 70
Study: 2301245

Group type: EXPERIMENTAL
Intervention: Nicardipine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Propranolol
Number of subjects: 0
Study: 7350294

Group type: EXPERIMENTAL
Intervention: Oxandrolone
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Human growth hormone (hGH)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Oxandrolone + Human growth hormone (Ox + hGH)
Number of subjects: 6

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 6
Study: 31528866

Group type: EXPERIMENTAL
Intervention: Grafted sinuses
Number of subjects: 12

Group type: COMPARATOR
Intervention: Nongrafted sinuses
Number of subjects: 12
Study: 28638060

Group type: EXPERIMENTAL
Intervention: Epidural group (Group E): TEA with levobupivacaine and dexmedetomidine, intravenous saline infusion
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Intravenous group (Group V): TEA with levobupivacaine, intravenous dexmedetomidine infusion
Number of subjects: 71

Group type: COMPARATOR
Intervention: Control group (Group C): TEA with levobupivacaine alone, intravenous saline infusion
Number of subjects: 71
Study: 25854859

Group type: COMPARATOR
Intervention: Pradigastat (1, 3, 10, 30, 100, or 300 mg)
Number of subjects: 178

Group type: COMPARATOR
Intervention: Pradigastat (1, 5, 10, or 25 mg)
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: Pradigastat (single and multiple doses)
Number of subjects: 178
Study: 24088535

Group type: EXPERIMENTAL
Intervention: Mindfulness Based Stress Reduction (MBSR) Intervention I (weekly group sessions + self‐instructing program)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mindfulness Based Stress Reduction (MBSR) Intervention II (self‐instructing program)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Controls (non‐MBSR)
Number of subjects: 0
Study: 21843685

Group type: EXPERIMENTAL
Intervention: Mifepristone 200 mg orally and misoprostol 800 mcg vaginally
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Mifepristone 200 mg
Number of subjects: 27
Study: 19121595

Group type: EXPERIMENTAL
Intervention: High-resolution Fd-OCT imaging
Number of subjects: 30
Study: 17920976

Group type: EXPERIMENTAL
Intervention: Intranasal fentanyl (INF) 180 mug +/‐ 2 doses of 60 mug at > or =5‐minute intervals
Number of subjects: 258

Group type: EXPERIMENTAL
Intervention: Intravenous morphine (IVM) 2.5 to 5 mg +/‐ 2 doses of 2.5 to 5 mg at > or =5‐minute intervals
Number of subjects: 258

Group type: COMPARATOR
Intervention: Baseline VRS
Number of subjects: 258

Group type: COMPARATOR
Intervention: Minutes to destination
Number of subjects: 258

Group type: COMPARATOR
Intervention: Higher baseline VRS
Number of subjects: 258

Group type: COMPARATOR
Intervention: No methoxyflurane use
Number of subjects: 258

Group type: COMPARATOR
Intervention: Back pain
Number of subjects: 258

Group type: COMPARATOR
Intervention: Safety and acceptability
Number of subjects: 258
Study: 15257846

Group type: EXPERIMENTAL
Intervention: Provider counseling, health education, and CHW support
Number of subjects: 217

Group type: COMPARATOR
Intervention: Provider counseling
Number of subjects: 217

Group type: COMPARATOR
Intervention: Provider counseling and health education
Number of subjects: 217
Study: 11239945

Group type: EXPERIMENTAL
Intervention: levodopa (on state)
Number of subjects: 20

Group type: COMPARATOR
Intervention: levodopa (off state)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: verbal working memory measure (on and off states)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: verbal working memory measure (on state)
Number of subjects: 20
Study: 9659015

Group type: EXPERIMENTAL
Intervention: Isoflurane (n = 25)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Halothane (n = 26)
Number of subjects: 51
Study: 8698737

Group type: EXPERIMENTAL
Intervention: Dexverapamil plus chemotherapy (vindesine/etoposide)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Chemotherapy (vindesine/etoposide) alone
Number of subjects: 54
Study: 2549243

Group type: EXPERIMENTAL
Intervention: High fibre, low fat and low sodium diet
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 34
Study: 302111

Group type: EXPERIMENTAL
Intervention: Continuous infusion of vasopressin via peripheral vein
Number of subjects: 25

Group type: COMPARATOR
Intervention: Continuous infusion of vasopressin via superior mesenteric artery (SMA)
Number of subjects: 25
Study: 30773030

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIT) for 9 months (4×4-minute intervals at 85%-95% of peak effort)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Moderate-Intensity Continuous Training for 9 months (60%-80% of peak effort)
Number of subjects: 81
Study: 29627898

Group type: EXPERIMENTAL
Intervention: SSRI treatment with paroxetine for 8 weeks
Number of subjects: 178
Study: 27028170

Group type: EXPERIMENTAL
Intervention: Intensity-modulated radiotherapy (IMRT)
Number of subjects: 215

Group type: COMPARATOR
Intervention: 3-dimensional conformal radiotherapy (3DCRT)
Number of subjects: 215
Study: 25450993

Group type: EXPERIMENTAL
Intervention: Aerobic Training (AT)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Muscle Training (CT)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Both AT and CT
Number of subjects: 18
Study: 22455636

Group type: COMPARATOR
Intervention: PaO2 levels controlled at 80 ‐ 120 mm Hg during CPB (G1 group)
Number of subjects: 45

Group type: COMPARATOR
Intervention: PaO2 levels controlled at 120 ‐ 200 mm Hg during CPB (G2 group)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: PaO2 levels uncontrolled at 200 ‐ 400 mm Hg during CPB (G3 group)
Number of subjects: 45
Study: 20008967

Group type: EXPERIMENTAL
Intervention: Thinking of others with good trait or state self-control
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Thinking of others with bad trait or state self-control
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Salience of significant others
Number of subjects: 0
Study: 19230167

Group type: EXPERIMENTAL
Intervention: Oxybutynin
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Verapamil
Number of subjects: 20
Study: 16141019

Group type: EXPERIMENTAL
Intervention: Human patient simulator (SIM)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Human subjects in the operating room (OR)
Number of subjects: 36
Study: 12884163

Group type: EXPERIMENTAL
Intervention: Vancomycin therapy
Number of subjects: 165

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 165
Study: 10576371

Group type: EXPERIMENTAL
Intervention: PGE1 (120 microg/day for 5 days)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 20
Study: 8726538

Group type: EXPERIMENTAL
Intervention: Intranasal apomorphine monotherapy
Number of subjects: 11

Group type: COMPARATOR
Intervention: Levodopa/carbidopa
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Intranasal apomorphine
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Intranasal apomorphine with trimethobenzamide
Number of subjects: 11
Study: 1756271

Group type: EXPERIMENTAL
Intervention: melphalan (L-PAM)
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: cyclophosphamide, methotrexate, and fluorouracil (CMF)
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: post-operative radiation therapy (RT)
Number of subjects: 158

Group type: COMPARATOR
Intervention: chemotherapy alone
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: less than 4 positive nodes
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: greater than or equal to 4 positive nodes
Number of subjects: 158
Study: 7169959

Group type: EXPERIMENTAL
Intervention: Oestradiol diether (promestriene) administered via gynaecological capsules for 40 consecutive days
Number of subjects: 38

Group type: COMPARATOR
Intervention: Excipient (control) administered via gynaecological capsules for 40 consecutive days
Number of subjects: 38
Study: 6368883

Group type: EXPERIMENTAL
Intervention: Gemfibrozil
Number of subjects: 14

Group type: COMPARATOR
Intervention: Clofibrate
Number of subjects: 14
Study: 30471141

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) with APAP
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo with APAP
Number of subjects: 24
Study: 29320335

Group type: EXPERIMENTAL
Intervention: Intervention arm (physician training with communication guide and in-office sessions)
Number of subjects: 479

Group type: COMPARATOR
Intervention: Control arm (no intervention)
Number of subjects: 479

Group type: EXPERIMENTAL
Intervention: Intervention arm (physician training)
Number of subjects: 479
Study: 26700803

Group type: EXPERIMENTAL
Intervention: Global Postural Reeducation (GPR) program, three times a week for 40 minutes over 4 weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 20
Study: 25461782

Group type: EXPERIMENTAL
Intervention: Mindful Mood Balance (MMB)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Usual Depression Care (UDC)
Number of subjects: 100
Study: 22624423

Group type: EXPERIMENTAL
Intervention: Fluoride releasing resin-based (Heliosel F)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Glass ionomer (Fuji Triage)
Number of subjects: 60
Study: 19725847

Group type: EXPERIMENTAL
Intervention: Bicaval surgical technique
Number of subjects: 113

Group type: COMPARATOR
Intervention: Standard biatrial technique
Number of subjects: 113
Study: 17122448

Group type: COMPARATOR
Intervention: Dual ET-receptor blockade in controls
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Dual ET-receptor blockade in SCI
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Selective ET(A)-receptor blockade in SCI
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Electro-stimulated training in SCI
Number of subjects: 16
Study: 16283087

Group type: EXPERIMENTAL
Intervention: Theory of mind training (25 minutes per day for 5-10 days)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Executive function training (25 minutes per day for 5-10 days)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 27
Study: 12972720

Group type: EXPERIMENTAL
Intervention: Zaleplon (ZAL)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 10
Study: 10380243

Group type: EXPERIMENTAL
Intervention: External focus on the club swing
Number of subjects: 22

Group type: COMPARATOR
Intervention: Internal focus on the arm swing
Number of subjects: 22
Study: 8555852

Group type: EXPERIMENTAL
Intervention: Cognitive behaviour therapy (CBT) - 16 individual weekly sessions in addition to medical care
Number of subjects: 60

Group type: COMPARATOR
Intervention: Medical care alone
Number of subjects: 60
Study: 1810080

Group type: EXPERIMENTAL
Intervention: Pamidronate 75 mg daily
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Pamidronate 150 mg daily
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 6343815

Group type: EXPERIMENTAL
Intervention: Salbutamol powder (Ventolin, 200 micrograms) via Rotahaler (SR)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Terbutaline sulphate (Bricanyl, 500 micrograms) via Misthaler (TM)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Preference for Ventolin Rotahaler
Number of subjects: 25
Study: 30528802

Group type: EXPERIMENTAL
Intervention: Intense dose-dense epirubicin, paclitaxel, cyclophosphamide (iddEPC)
Number of subjects: 945

Group type: COMPARATOR
Intervention: Weekly paclitaxel, liposomal doxorubicin (plus carboplatin in TNBC) (PM(Cb))
Number of subjects: 945
Study: 28198120

Group type: EXPERIMENTAL
Intervention: Lecithinized curcumin (1 g/day for 6 weeks)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Unformulated curcumin (1 g/day for 6 weeks)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo (for 6 weeks)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: All groups (including control)
Number of subjects: 120
Study: 25706743

Group type: EXPERIMENTAL
Intervention: Narratives acknowledging individual responsibility while emphasizing social determinants of obesity
Number of subjects: 718

Group type: COMPARATOR
Intervention: Narratives not acknowledging individual responsibility
Number of subjects: 718
Study: 24401555

Group type: EXPERIMENTAL
Intervention: WDYD Web-based brief alcohol intervention (single-session and fully automated)
Number of subjects: 907

Group type: COMPARATOR
Intervention: Assessment only (control condition)
Number of subjects: 907
Study: 23078651

Group type: EXPERIMENTAL
Intervention: Pimobendan (Vetmedin capsules)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study: 19177449

Group type: EXPERIMENTAL
Intervention: Standard-dose tacrolimus (10-15 ng/mL) plus intravenous MMF (1 g twice daily) with corticosteroids
Number of subjects: 60

Group type: COMPARATOR
Intervention: Reduced-dose tacrolimus (5-8 ng/mL) plus intravenous MMF (1 g twice daily) with corticosteroids
Number of subjects: 60
Study: 17150015

Group type: EXPERIMENTAL
Intervention: Gene and cell therapies for myocardial neovascularisation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination therapies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Novel imaging techniques
Number of subjects: 0
Study: 15566035

Group type: EXPERIMENTAL
Intervention: Pneumococcal polysaccharide vaccine
Number of subjects: 27
Study: 11226121

Group type: EXPERIMENTAL
Intervention: Evidence-based medicine (EBM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 10504080

Group type: EXPERIMENTAL
Intervention: Alcohol epithelial removal (20% ethanol solution applied for 20 seconds)
Number of subjects: 190

Group type: COMPARATOR
Intervention: Mechanical epithelial removal (Desmarres blade)
Number of subjects: 190
Study: 8695463

Group type: EXPERIMENTAL
Intervention: Assessment and treatment in primary care using a trained nurse
Number of subjects: 0
Study: 1654136

Group type: EXPERIMENTAL
Intervention: Intravenous diazepam (four consecutive, logarithmically increasing doses)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 7048591

Group type: EXPERIMENTAL
Intervention: Povidone-iodine irrigation
Number of subjects: 592

Group type: COMPARATOR
Intervention: Control (no irrigation)
Number of subjects: 592